Category
Blog
-
2023
-
EU Expands Dupixent’s Authorization for Eosinophilic Esophagitis
-
FDA Approves Sutimlimab-jome with Long-Term Safety, Efficacy Data for Cold Agglutinin Disease
-
NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures
-
Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on dialysis
-
ICER Questions Benefit of Fezolinetant for Hot Flashes
-
Medicago to Shut Down Despite COVID-19 Vaccine Approval
-
Gilead buoyed by Trodelvy OK in new breast cancer use
-
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
-
Eisai’s New Alzheimer’s Drug Leqembi Hits the U.S. Market
-
Mesoblast Resubmits BLA for Remestemcel-L